Cullen Investment Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.69M Buy
123,864
+13,869
+13% +$1.12M 1.17% 25
2026
Q1
$9.53M Buy
109,995
+5,516
+5% +$528K 1.26% 21
2025
Q4
$10.2M Buy
104,479
+11,375
+12% +$1.1M 1.32% 18
2025
Q3
$9.09M Buy
93,104
+7,183
+8% +$660K 1.2% 23
2025
Q2
$7.49M Buy
85,921
+5,802
+7% +$492K 1.06% 27
2025
Q1
$7.2M Buy
80,119
+4,925
+7% +$441K 1.09% 24
2024
Q4
$6.01M Buy
75,194
+1,140
+2% +$98.7K 0.89% 30
2024
Q3
$6.67M Buy
74,054
+1,024
+1% +$86.1K 0.99% 27
2024
Q2
$5.75M Buy
73,030
+1,803
+3% +$148K 0.92% 29
2024
Q1
$6.07M Buy
71,227
+3,031
+4% +$259K 0.96% 30
2023
Q4
$5.62M Buy
+68,196
New +$5.2M 0.98% 27

Other funds holding MDT

Cullen Investment Group's MDT Position: Q2 2026 in Review

Cullen Investment Group increased its Medtronic (MDT) stake by 13% in Q2 2026, buying an estimated $1.12M and bringing the position to 123,864 shares worth $9.69M. The position accounts for 1.17% of the portfolio, ranked #25.

Cullen Investment Group first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.2M in Q4 2025. 428 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cullen Investment Group held 123,864 shares of Medtronic worth $9.69M as of Q2 2026.
  • Cullen Investment Group bought 13,869 Medtronic shares in Q2 2026, an estimated $1.12M.
  • Medtronic made up 1.17% of Cullen Investment Group's portfolio in Q2 2026, its #25 holding.
  • Cullen Investment Group first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Cullen Investment Group's Medtronic position peaked at $10.2M in Q4 2025.
  • 428 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cullen Investment Group's 13F filing for Q2 2026, filed 9 Jul 2026.